- Published at
- by manilatimes.net
positive
positive
News for Pharma Mar, S.A. (PHM.MC)
- Published at
- by gurufocus.com
mixedmixedJazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse Glioma
PR NewswireDUBLIN, April 23, 2025 Statistically significant and clinically meaningful progression-free survival (PFS) and overall survival (OS) data for Ze- Published at
- by prnewswire.com
mixedmixedJazz Pharmaceuticals to Showcase Rapidly Expanding Oncology Pipeline and Advances in Current Product Portfolio at ASCO 2023
Data from multiple studies of investigational bispecific drug zanidatamab, including pivotal Phase 2 biliary tract cancers (BTC) trial results, demonstrate...- Published at
- by prnewswire.com
mixedmixedJazz Pharmaceuticals to Present Data at 2023 AACR Annual Meeting Showcasing New Zepzelca® (lurbinectedin) Data and Expanded Oncology Pre-Clinical and Clinical Pipeline
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company, along with its partners, will present five new abstracts at the...- Published at
- by seekingalpha.com
neutralneutralPharma Mar, S.A. (PHMMF) Q4 2022 Earnings Call Transcript
Pharma Mar, S.A. (OTCPK:PHMMF) Q4 2022 Earnings Conference Call March 1, 2023 7:00 AM ETCompany ParticipantsJose Luis - Head, Investor Relations & Capital MarketsMaria Luisa de Francia...- Published at
- by etfdailynews.com
positivepositivePharma Mar, S.A. (OTCMKTS:PHMMF) Sees Significant Increase in Short Interest
Read Pharma Mar, S.A. (OTCMKTS:PHMMF) Sees Significant Increase in Short Interest at ETF Daily News- Published at
- by etfdailynews.com
positivepositivePharma Mar, S.A. (OTCMKTS:PHMMF) Short Interest Up 1,400.0% in May
Read Pharma Mar, S.A. (OTCMKTS:PHMMF) Short Interest Up 1,400.0% in May at ETF Daily News- Published at
- by etfdailynews.com
positivepositiveShort Interest in Pharma Mar, S.A. (OTCMKTS:PHMMF) Declines By 86.7%
Read Short Interest in Pharma Mar, S.A. (OTCMKTS:PHMMF) Declines By 86.7% at ETF Daily News- Published at
- by etfdailynews.com
positivepositiveShort Interest in Pharma Mar, S.A. (OTCMKTS:PHMMF) Rises By 200.0%
Read Short Interest in Pharma Mar, S.A. (OTCMKTS:PHMMF) Rises By 200.0% at ETF Daily News- Published at
- by prnewswire.com
neutralneutralJazz Pharmaceuticals Announces First Patient Enrolled in EMERGE-201 Phase 2 Basket Trial Evaluating Zepzelca® (lurbinectedin) Monotherapy in Patients with Select Advanced or Metastatic Solid Tumors
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the first patient was enrolled in EMERGE-201, a Phase 2 clinical trial evaluating the...- Published at
- by seekingalpha.com
neutralneutralPharma Mar, S.A. (PHMMF) Management on Q4 2021 Results - Earnings Call Transcript
Pharma Mar, S.A. (OTCPK:PHMMF) Q4 2021 Results Conference Call March 01, 2022 07:00 AM ET Company Participants Jose Luis Moreno - Head, IR and Capital Markets Luis Mora - Managing Director...- Published at
- by thestreet.com
mixedmixedOutlook On The Multiple Myeloma Drugs Global Market To 2026 - By Therapy, Drug Type, End-user, Distribution Channel And Region
DUBLIN, Aug. 25, 2021 /PRNewswire/ -- The "Multiple Myeloma Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026"